RETRACTION: Atractylenolide III alleviates sepsis-mediated lung injury via inhibition of FoxO1 and VNN1 protein

Key Points

• This work aimed to explore how Atractylenolide III affects lung injury caused by sepsis.
• Analyzed the efficacy of Atractylenolide III in a sepsis model
• Examined interactions with FoxO1 and VNN1 proteins
• Atractylenolide III improved lung injury outcomes
• Decreased activity of FoxO1 and VNN1 proteins